372 followers
RT @thepcrcompany: Using #SensiFAST, IRS4-expression was shown to confers resistance to HER2-targeted therapy in #BreastCancer >> https://t…
RT @thepcrcompany: Using #SensiFAST, IRS4-expression was shown to confers resistance to HER2-targeted therapy in #BreastCancer >> https://t…
IRS4 Induces Mammary Tumorigenesis & Confers Resistance to HER2-Targeted Therapy @hetAVL @NatureComms https://t.co/gKvjQq0Lux
Using #SensiFAST, IRS4-expression was shown to confers resistance to HER2-targeted therapy in #BreastCancer >> https://t.co/AzwjHLxoe0 🔬⚗ https://t.co/Qp9WQ4TnSV